Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer's Disease

• Published in: Cells (Basel, Switzerland) Switzerland), 2021-04, Vol.10 (5), p.993
• Main Authors: Delgado-Peraza, Francheska, Nogueras-Ortiz, Carlos J, Volpert, Olga, Liu, Dong, Goetzl, Edward J, Mattson, Mark P, Greig, Nigel H, Eitan, Erez, Kapogiannis, Dimitrios
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; Alzheimer’s; Animal models; Antibodies; Biomarkers; Biopsy; Brain; Cerebral cortex; Complement component C1q; exosomes; extracellular vesicles; Hippocampus; Membranes; Mutation; Neurodegenerative diseases; Neurological diseases; Pathology; Phosphatase; Plasma; Precision medicine; Proteins; Tau; Tau protein; transgenic; β-Amyloid
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells10050993

Circulating neuronal extracellular vesicles (NEVs) of Alzheimer's disease (AD) patients show high Tau and β-amyloid (Aβ) levels, whereas their astrocytic EVs (AEVs) contain high complement levels. To validate EV proteins as AD biomarkers, we immunocaptured NEVs and AEVs from plasma collected from fifteen wild type (WT), four 2xTg-AD, nine 5xFAD, and fifteen 3xTg-AD mice and assessed biomarker relationships with brain tissue levels. NEVs from 3xTg-AD mice had higher total Tau ( = 0.03) and p181-Tau ( = 0.0004) compared to WT mice. There were moderately strong correlations between biomarkers in NEVs and cerebral cortex and hippocampus (total Tau: cortex, r = 0.4, = 0.009; p181-Tau: cortex, r = 0.7, < 0.0001; hippocampus, r = 0.6, < 0.0001). NEVs from 5xFAD compared to other mice had higher Aβ42 ( < 0.005). NEV Aβ42 had moderately strong correlations with Aβ42 in cortex (r = 0.6, = 0.001) and hippocampus (r = 0.7, < 0.0001). AEV C1q was elevated in 3xTg-AD compared to WT mice ( = 0.005); AEV C1q had moderate-strong correlations with C1q in cortex (r = 0.9, < 0.0001) and hippocampus (r = 0.7, < 0.0001). Biomarkers in circulating NEVs and AEVs reflect their brain levels across multiple AD mouse models supporting their potential use as a "liquid biopsy" for neurological disorders.